Monitoring of concentrations of clobazam and norclobazam in serum and saliva of children with epilepsy (Q48728056)

15 February 2018

title

Monitoring of concentrations of clobazam and norclobazam in serum and saliva of children with epilepsy (English)

1 reference

15 February 2018

1 reference

A H Bardy

1 reference

15 February 2018

T Seppälä

1 reference

15 February 2018

T Salokorpi

1 reference

15 February 2018

M L Granström

1 reference

15 February 2018

P Santavuori

1 reference

15 February 2018

publication date

1 May 1991

1 reference

15 February 2018

published in

Brain and Development

1 reference

15 February 2018

volume

1 reference

15 February 2018

issue

1 reference

15 February 2018

page(s)

174-179

1 reference

15 February 2018

Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: the place of clobazam

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Established anticonvulsants and treatment of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Simultaneous screening and quantitative analysis of benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Benzodiazepines in the treatment of children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Pharmacology of anti-anxiety drugs with special reference to clobazam

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Intermittent clobazam for catamenial epilepsy: tolerance avoided

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

Discontinuation of clonazepam after long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980025-8

7 January 2021

10.1016/S0387-7604(12)80025-8

Identifiers

DOI

0 references

1 reference

15 February 2018